Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Determination of Mesothelin Levels in Pleural Effusion Does Not Help Predict Survival of Patients With Malignant Pleural Mesothelioma.

Fontana V, Pistillo MP, Vigani A, Canessa PA, Berisso G, Giannoni U, Ferro P, Franceschini MC, Carosio R, Tonarelli M, Rossi C, Dessanti P, Roncella S.

Anticancer Res. 2019 Sep;39(9):5219-5223. doi: 10.21873/anticanres.13719.

PMID:
31519636
2.

IFN-γ upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1/PD-L1 blockade.

Pistillo MP, Carosio R, Banelli B, Morabito A, Mastracci L, Ferro P, Varesano S, Venè R, Poggi A, Roncella S.

Cell Mol Immunol. 2019 Jun 19. doi: 10.1038/s41423-019-0245-x. [Epub ahead of print] No abstract available.

PMID:
31217525
3.

The Correlation of Serum Mesothelin Level With Pleural Thickness in Malignant Pleural Mesothelioma Makes it a Valuable Tool for Monitoring Tumor Progression.

Fontana V, Vigani A, Pistillo MP, Giannoni U, Rosemberg I, Canessa PA, Berisso G, Ferro P, Franceschini MC, Tonarelli M, Roncella S.

J Thorac Oncol. 2019 May;14(5):e92-e94. doi: 10.1016/j.jtho.2018.12.026. No abstract available.

PMID:
31027749
4.

Use of Serum Mesothelin as an Indicator of Tumor Progression in Routine Clinical Practice of Malignant Pleural Mesothelioma Treatment.

Vigani A, Pistillo MP, Fontana V, Giannoni U, Rosenberg I, Canessa PA, Berisso G, Ferro P, Franceschini MC, Tonarelli M, Roncella S.

J Thorac Oncol. 2018 Aug;13(8):e143-e145. doi: 10.1016/j.jtho.2018.03.015. No abstract available.

5.

Evaluation of RET Gene Rearrangement by Fluorescence In Situ Hybridization in Malignant Mesothelioma.

Salvi S, Ravetti JL, Arena G, Musso C, Varesano S, Pistillo MP, Canessa PA, Ferro P, Fedeli F, Roncella S.

J Thorac Oncol. 2018 Jan;13(1):e12-e14. doi: 10.1016/j.jtho.2017.09.1957. No abstract available.

6.

Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma.

Truini A, Coco S, Nadal E, Genova C, Mora M, Dal Bello MG, Vanni I, Alama A, Rijavec E, Biello F, Barletta G, Merlo DF, Valentino A, Ferro P, Ravetti GL, Stigliani S, Vigani A, Fedeli F, Beer DG, Roncella S, Grossi F.

Oncotarget. 2017 Aug 2;8(40):68627-68640. doi: 10.18632/oncotarget.19800. eCollection 2017 Sep 15.

7.

FISH Analysis of Crizotinib Target Genes ROS1/ALK/MET in Malignant Mesothelioma.

Salvi S, Varesano S, Boccardo S, Ravetti JL, Canessa PA, Pistillo MP, Ferro P, Fedeli F, Roncella S.

J Thorac Oncol. 2017 Aug;12(8):e116-e118. doi: 10.1016/j.jtho.2017.03.015. No abstract available.

8.

Comparison of the Diagnostic Performance of Fibulin-3 and Mesothelin in Patients with Pleural Effusions from Malignant Mesothelioma.

Battolla E, Canessa PA, Ferro P, Franceschini MC, Fontana V, Dessanti P, Pinelli V, Morabito A, Fedeli F, Pistillo MP, Roncella S.

Anticancer Res. 2017 Mar;37(3):1387-1391.

PMID:
28314308
9.

EGFR Status in Mesothelioma: Possible Implications for the Efficacy of Anti-EGFR and Anti-MET Therapies.

Salvi S, Varesano S, Boccardo S, Ravetti JL, Canessa PA, Pistillo MP, Ferro P, Fedeli F, Roncella S.

J Thorac Oncol. 2016 Jun;11(6):e78-80. doi: 10.1016/j.jtho.2016.03.001. No abstract available.

10.

CTLA-4 in mesothelioma patients: tissue expression, body fluid levels and possible relevance as a prognostic factor.

Roncella S, Laurent S, Fontana V, Ferro P, Franceschini MC, Salvi S, Varesano S, Boccardo S, Vigani A, Morabito A, Canessa PA, Giannoni U, Rosenberg I, Valentino A, Fedeli F, Merlo DF, Ceppi M, Riggio S, Romani M, Saverino D, Poggi A, Pistillo MP.

Cancer Immunol Immunother. 2016 Aug;65(8):909-17. doi: 10.1007/s00262-016-1844-3. Epub 2016 May 20.

PMID:
27207606
11.

MET Gene Status in Malignant Mesothelioma Using Fluorescent In Situ Hybridization.

Varesano S, Salvi S, Boccardo S, Ravetti JL, Pistillo MP, Canessa PA, Ferro P, Fedeli F, Roncella S.

J Thorac Oncol. 2016 Feb;11(2):e28-30. doi: 10.1016/j.jtho.2015.10.019. No abstract available.

12.

Amplification of MET in a Patient with Malignant Pleural Mesothelioma.

Varesano S, Salvi S, Boccardo S, Ravetti JL, Ferro P, Canessa PA, Fedeli F, Pistillo MP, Roncella S.

J Thorac Oncol. 2015 Oct;10(10):e103-4. doi: 10.1097/JTO.0000000000000638. No abstract available.

13.

Mesothelin in serum and pleural effusion in the diagnosis of malignant pleural mesothelioma with non-positive cytology.

Franceschini MC, Ferro P, Canessa PA, Battolla E, Dessanti P, Valentino A, Casolari L, Fontana V, Pezzi R, Fedeli F, Pistillo MP, Roncella S.

Anticancer Res. 2014 Dec;34(12):7425-9.

PMID:
25503183
14.

Status of Anaplastic Lymphoma Kinase (ALK) in malignant mesothelioma.

Varesano S, Leo C, Boccardo S, Salvi S, Truini M, Ferro P, Fedeli F, Canessa PA, Dessanti P, Pistillo MP, Roncella S.

Anticancer Res. 2014 May;34(5):2589-92.

PMID:
24778081
15.

Clinical value of mesothelin in pleural effusions versus histology by medical thoracoscopy: brief report.

Canessa PA, Ferro P, Manta C, Sivori M, Franceschini MC, Fedeli F, Roncella S.

Med Oncol. 2013;30(3):649. doi: 10.1007/s12032-013-0649-x. Epub 2013 Jul 20.

PMID:
23873013
16.

Mesothelin is more useful in pleural effusion than in serum in the diagnosis of pleural mesothelioma.

Ferro P, Canessa PA, Battolla E, Dessanti P, Franceschini MC, Chiaffi L, Morabito A, Fontana V, Pezzi R, Fedeli F, Pistillo MP, Roncella S.

Anticancer Res. 2013 Jun;33(6):2707-13.

PMID:
23749930
17.

Evaluation of soluble mesothelin-related peptide as a diagnostic marker of malignant pleural mesothelioma effusions: its contribution to cytology.

Canessa PA, Franceschini MC, Ferro P, Battolla E, Dessanti P, Manta C, Sivori M, Pezzi R, Fontana V, Fedeli F, Pistillo MP, Roncella S.

Cancer Invest. 2013 Jan;31(1):43-50. doi: 10.3109/07357907.2012.749265. Epub 2012 Dec 18.

PMID:
23249166
18.

Clinical relevance of human mammaglobin mRNA in pleural effusion from patients undergoing thoracoscopy: a pilot study.

Canessa PA, Manta C, Ferro P, Franceschini MC, Sivori M, Fontana V, Fedeli F, Pistillo MP, Roncella S.

Int J Biol Markers. 2012 Jul 19;27(2):e99-104. doi: 10.5301/JBM.2012.9305.

PMID:
22653740
19.

Human mammaglobin transcript amplification for differential diagnosis in a breast cancer metastatic to dura mater.

Dono M, Ferro P, Franceschini MC, Dessanti P, Bacigalupo B, Cibei E, Capellini C, Amoroso D, Camerini A, Fedeli F, Roncella S.

Anticancer Res. 2011 Mar;31(3):1061-4.

PMID:
21498739
20.

Detection of circulating tumour cells in breast cancer patients using human mammaglobin RT-PCR: association with clinical prognostic factors.

Ferro P, Franceschini MC, Bacigalupo B, Dessanti P, Falco E, Fontana V, Gianquinto D, Pistillo MP, Fedeli F, Roncella S.

Anticancer Res. 2010 Jun;30(6):2377-82.

PMID:
20651396
21.

Diagnosis and origin determination of malignant pleural effusions through the use of the breast cancer marker human mammaglobin.

Roncella S, Ferro P, Franceschini MC, Bacigalupo B, Dessanti P, Sivori M, Carletti AM, Fontana V, Canessa PA, Pistillo MP, Fedeli F.

Diagn Mol Pathol. 2010 Jun;19(2):92-8. doi: 10.1097/PDM.0b013e3181ba6c78.

PMID:
20502186
22.

PNAEmu can significantly reduce Burkitt's lymphoma tumor burden in a SCID mice model: cells dissemination similar to the human disease.

Matis S, Mariani MR, Cutrona G, Cilli M, Piccardi F, Daga A, Damonte G, Millo E, Moroni M, Roncella S, Fedeli F, Boffa LC, Ferrarini M.

Cancer Gene Ther. 2009 Oct;16(10):786-93. doi: 10.1038/cgt.2009.26. Epub 2009 Apr 10.

PMID:
19363465
23.

Molecular detection of human mammaglobin in cerebrospinal fluid from breast cancer patient with leptomeningeal carcinomatosis.

Dono M, Ferro P, Benedetti L, Capellini C, Moroni M, Dessanti P, Bacigalupo B, Tartaglione A, Battolla E, Fedeli F, Roncella S.

J Neurooncol. 2009 Feb;91(3):295-8. doi: 10.1007/s11060-008-9711-5. Epub 2008 Oct 9.

PMID:
18841443
24.

Assessment of RT-PCR detection of human mammaglobin for the diagnosis of breast cancer derived pleural effusions.

Roncella S, Ferro P, Bacigalupo B, Dessanti P, Pronzato P, Franceschini MC, Pratticò L, Carletti AM, Canessa PA, Fontana V, Fais F, Pistillo MP, Fedeli F.

Diagn Mol Pathol. 2008 Mar;17(1):28-33. doi: 10.1097/PDM.0b013e31811ffe3b.

PMID:
18303409
25.

The peptide nucleic acid targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitt's lymphoma lacks immunogenicity: follow-up characterization of PNAEmu-NLS.

Cutrona G, Boffa LC, Mariani MR, Matis S, Damonte G, Millo E, Roncella S, Ferrarini M.

Oligonucleotides. 2007 Spring;17(1):146-50.

PMID:
17461771
26.

Lack of mutagenicity and clastogenicity of PNAEmu-NLS targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitt's lymphoma.

Boffa LC, Menichini P, Bolognesi C, Cutrona G, Roncella S, Damonte GL, Millo E, Mariani MR, Matis S, Russo D, Ciliutti P, Ferrarini M.

Mutat Res. 2007 Apr 2;628(2):129-37. Epub 2007 Jan 8. Erratum in: Mutat Res. 2007 Dec 1;634(1-2):245.

PMID:
17267263
27.

Inhibition of Burkitt's lymphoma cells growth in SCID mice by a PNA specific for a regulatory sequence of the translocated c-myc.

Boffa LC, Cutrona G, Cilli M, Matis S, Damonte G, Mariani MR, Millo E, Moroni M, Roncella S, Fedeli F, Ferrarini M.

Cancer Gene Ther. 2007 Feb;14(2):220-6. Epub 2006 Oct 20.

PMID:
17053816
28.

Relationship between human mammaglobin mRNA expression in breast cancer tissue and clinico-pathologic features of the tumors.

Roncella S, Ferro P, Bacigalupo B, Dessanti P, Giannico A, Gorji N, Moroni M, Tozzini S, Pensa F, Gianquinto D, Fais F, Pronzato P, Fedeli F.

J Exp Clin Cancer Res. 2006 Mar;25(1):65-72.

PMID:
16761620
29.

Expression of human mammaglobin gene in pleural effusions of patients with malignant mesothelioma.

Carletti AM, Roncella S, Canessa PA, Pratticò L, Maggiani R, Bacigalupo B, Ferro P, Fedeli F.

Thorax. 2006 Mar;61(3):271. No abstract available.

30.

Three cases of ophthalmomyiasis externa by sheep botfly Oestrus ovis in Italy.

Dono M, Bertonati MR, Poggi R, Teneggi E, Maddalo F, Via F, Orlandi R, Maroli M, Roncella S, Fedeli F, Battolla E.

New Microbiol. 2005 Oct;28(4):365-8.

PMID:
16386021
31.

Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood.

Roncella S, Ferro P, Bacigalupo B, Pronzato P, Tognoni A, Falco E, Gianquinto D, Ansaldo V, Dessanti P, Fais F, Rosai J, Fedeli F.

J Exp Clin Cancer Res. 2005 Jun;24(2):265-71.

PMID:
16110760
32.

Therapeutically promising PNA complementary to a regulatory sequence for c-myc: pharmacokinetics in an animal model of human Burkitt's lymphoma.

Boffa LC, Cutrona G, Cilli M, Mariani MR, Matis S, Pastorino M, Damonte G, Millo E, Roncella S, Ferrarini M.

Oligonucleotides. 2005 Summer;15(2):85-93.

PMID:
15989423
33.

CCL19 and CXCL12 trigger in vitro chemotaxis of human mantle cell lymphoma B cells.

Corcione A, Arduino N, Ferretti E, Raffaghello L, Roncella S, Rossi D, Fedeli F, Ottonello L, Trentin L, Dallegri F, Semenzato G, Pistoia V.

Clin Cancer Res. 2004 Feb 1;10(3):964-71.

34.

Heterogeneous expression of interleukin-18 and its receptor in B-cell lymphoproliferative disorders deriving from naive, germinal center, and memory B lymphocytes.

Airoldi I, Raffaghello L, Cocco C, Guglielmino R, Roncella S, Fedeli F, Gambini C, Pistoia V.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):144-54.

35.

Cytokeratin-positive malignant solitary fibrous tumour of the pleura: an unusual pitfall in the diagnosis of pleural spindle cell neoplasms.

Cavazza A, Rossi G, Agostini L, Roncella S, Ferro P, Fedeli F.

Histopathology. 2003 Dec;43(6):606-8. No abstract available.

PMID:
14636263
36.

[Poorly differentiated breast carcinoma with an abundant myoepithelial component: morphologic and immunohistochemical features and mammaglobin gene expression ].

Bonadio AG, Ferro P, Moroni M, Gorji N, Giannico A, Dessanti P, Fais F, Bacigalupo B, Roncella S, Fedeli F.

Pathologica. 2003 Aug;95(4):209-13. Italian.

PMID:
14577206
37.

Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer.

Cutrona G, Carpaneto EM, Ponzanelli A, Ulivi M, Millo E, Scarfì S, Roncella S, Benatti U, Boffa LC, Ferrarini M.

Cancer Res. 2003 Oct 1;63(19):6144-8.

38.

CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL.

Cutrona G, Tasso P, Dono M, Roncella S, Ulivi M, Carpaneto EM, Fontana V, Comis M, Morabito F, Spinelli M, Frascella E, Boffa LC, Basso G, Pistoia V, Ferrarini M.

Br J Cancer. 2002 Jun 5;86(11):1776-85.

39.

Analysis of stepwise genetic changes in an AIDS-related Burkitt's lymphoma.

Fais F, Fronza G, Roncella S, Inga A, Campomenosi P, Cutrona G, Pezzolo A, Fedeli F, Abbondandolo A, Chiorazzi N, Pistoia V, Ferrarini M.

Int J Cancer. 2000 Dec 1;88(5):744-50.

40.

Late Epstein-Barr virus infection of a hepatosplenic gamma delta T-cell lymphoma arising in a kidney transplant recipient.

Roncella S, Cutrona G, Truini M, Airoldi I, Pezzolo A, Valetto A, Di Martino D, Dadati P, De Rossi A, Ulivi M, Fontana I, Nocera A, Valente U, Ferrarini M, Pistoia V.

Haematologica. 2000 Mar;85(3):256-62.

41.

Chromosomal aberrations evaluated by CGH, FISH and GTG-banding in a case of AIDS-related Burkitt's lymphoma.

Zunino A, Viaggi S, Ottaggio L, Fronza G, Schenone A, Roncella S, Abbondandolo A.

Haematologica. 2000 Mar;85(3):250-5.

42.

Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal.

Cutrona G, Carpaneto EM, Ulivi M, Roncella S, Landt O, Ferrarini M, Boffa LC.

Nat Biotechnol. 2000 Mar;18(3):300-3.

PMID:
10700145
43.

Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients.

Colombo M, Dono M, Gazzola P, Roncella S, Valetto A, Chiorazzi N, Mancardi GL, Ferrarini M.

J Immunol. 2000 Mar 1;164(5):2782-9.

44.

An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins.

Tazzari PL, de Totero D, Bolognesi A, Testoni N, Pileri S, Roncella S, Reato G, Stein H, Gobbi M, Stirpe F.

Haematologica. 1999 Nov;84(11):988-95.

45.

Expression of CD10 by human T cells that undergo apoptosis both in vitro and in vivo.

Cutrona G, Leanza N, Ulivi M, Melioli G, Burgio VL, Mazzarello G, Gabutti G, Roncella S, Ferrarini M.

Blood. 1999 Nov 1;94(9):3067-76.

PMID:
10556191
46.

Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas.

Fais F, Gaidano G, Capello D, Gloghini A, Ghiotto F, Roncella S, Carbone A, Chiorazzi N, Ferrarini M.

Leukemia. 1999 Jul;13(7):1093-9.

47.

Identification of HSP-60 as the specific antigen of IgM produced by BRG-lymphoma cells.

Musante L, Ulivi M, Cutrona G, Chiorazzi N, Roncella S, Candiano G, Ferrarini M.

Electrophoresis. 1999 Apr-May;20(4-5):1092-7.

PMID:
10344290
48.

Apoptosis induced by crosslinking of CD4 on activated human B cells.

Cutrona G, Leanza N, Ulivi M, Majolini MB, Taborelli G, Zupo S, Baldari CT, Roncella S, Ferrarini M.

Cell Immunol. 1999 Apr 10;193(1):80-9.

PMID:
10202115
49.

Derivative chromosome 17 in a case of Burkitt lymphoma with 8;14 translocation.

Ottaggio L, Moro F, Fronza G, Roncella S, Bozzo S, Campomenosi P, Iga A, Ferranini M, Abbondandolo A.

Cancer Genet Cytogenet. 1999 Apr;110(1):1-6.

PMID:
10198614
50.

Patterns of cytokine expression in AIDS-related non-Hodgkin's lymphoma.

Pastore C, Gaidano G, Ghia P, Fassone L, Cilia AM, Gloghini A, Capello D, Buonaiuto D, Gonella S, Roncella S, Carbone A, Saglio G.

Br J Haematol. 1998 Oct;103(1):143-9.

PMID:
9792301

Supplemental Content

Loading ...
Support Center